Literature DB >> 8529683

Atypical Kawasaki disease with peripheral gangrene and myocardial infarction: therapeutic implications.

M von Planta1, M Fasnacht, C Holm, S Fanconi, R A Seger.   

Abstract

We describe a 2-month-old girl with atypical Kawasaki disease (KD) complicated by peripheral gangrene and myocardial infarction. Peripheral ischaemia leading to gangrene is a rare but serious complication of KD in infants younger than 7 months of age. Treatment has been targeted at reducing arterial inflammation, arteriospasm and thrombosis. We report the first patient with incomplete KD and peripheral ischaemia in whom therapy with prostaglandin E1 (PGE1) as vasodilating and antithrombotic agent appeared successful, restoring hand and foot perfusion without significant long-term sequelae. However, PGE1 could have supported development of myocardial infarction by shunting blood away from ischaemic areas distal to a giant coronary artery aneurysm with beginning thrombosis. CONCLUSION. Atypical KD with peripheral gangrene appears to react favourably to treatment with PGE1, but needs careful monitoring to detect early signs of cardiac ischaemia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8529683     DOI: 10.1007/bf01959792

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  20 in total

1.  Atypical Kawasaki disease: an often missed diagnosis.

Authors:  K Boven; E R De Graeff-Meeder; W Spliet; W Kuis
Journal:  Eur J Pediatr       Date:  1992-08       Impact factor: 3.183

Review 2.  Peripheral gangrene associated with Kawasaki disease.

Authors:  S Tomita; K Chung; M Mas; S Gidding; S T Shulman
Journal:  Clin Infect Dis       Date:  1992-01       Impact factor: 9.079

3.  Cardiac sequelae of Kawasaki disease in Japan: statistical analysis.

Authors:  Y Nakamura; Y Fujita; M Nagai; H Yanagawa; Y Imada; S Okawa; T Kawasaki; H Kato
Journal:  Pediatrics       Date:  1991-12       Impact factor: 7.124

4.  Fever, diarrhea, anemia, rash, and acrocyanosis in a 2-month-old girl.

Authors:  M J Chusid; T T Tang
Journal:  J Pediatr       Date:  1978-12       Impact factor: 4.406

5.  The treatment of Kawasaki syndrome with intravenous gamma globulin.

Authors:  J W Newburger; M Takahashi; J C Burns; A S Beiser; K J Chung; C E Duffy; M P Glode; W H Mason; V Reddy; S P Sanders
Journal:  N Engl J Med       Date:  1986-08-07       Impact factor: 91.245

6.  Kawasaki disease with severe peripheral ischemia: treatment with prostaglandin E1 infusion.

Authors:  M A Westphalen; M A McGrath; W Kelly; F J Moore; J B Ziegler
Journal:  J Pediatr       Date:  1988-03       Impact factor: 4.406

7.  Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. The TAO Study.

Authors:  J N Fiessinger; M Schäfer
Journal:  Lancet       Date:  1990-03-10       Impact factor: 79.321

8.  Amputating gangrene in Kawasaki disease.

Authors:  O H Teixeira; A H Pong; P Vlad
Journal:  Can Med Assoc J       Date:  1982-07-15       Impact factor: 8.262

9.  Clinical characteristics of myocardial infarction following Kawasaki disease: report of 11 cases.

Authors:  H Nakano; A Saito; K Ueda; K Nojima
Journal:  J Pediatr       Date:  1986-02       Impact factor: 4.406

10.  Spectrum of cardiovascular lesions in mucocutaneous lymph node syndrome: analysis of eight cases.

Authors:  J Fukushige; M R Nihill; D G McNamara
Journal:  Am J Cardiol       Date:  1980-01       Impact factor: 2.778

View more
  1 in total

1.  Peripheral Gangerene, an Unusual Presentation of Infantile Kawasaki: A Case Report and Literature Review.

Authors:  Fatemeh Tahghighi; Maryam Bakhtiari Koohsorkhi; Vahid Ziaee
Journal:  Case Rep Rheumatol       Date:  2021-04-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.